Basel: Roche, announced that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for an ...

It’s the first FDA approval for a pain medication in 25 years. How does the drug work, and who is it for?

Although fast food can be a tasty treat, many of your favorite menu items contain some very questionable preservatives, dyes, ...

US sweet protein startup Oobli has raised $18M and partnered with global ingredients giant Ingredion to develop ...

There exists no ‘amyloid cabal’” in Alzheimer’s research, neurologist Dennis Selkoe writes in response to Charles Piller’s ...

In a pioneering collaboration with AbbVie, Northwestern researchers have discovered a new way to potentially treat cancer by ...

Latent Labs has raised $50 million of new funding as it commercialises its GenAI technology for designing new proteins for ...

A research team, affiliated with UNIST has unveiled soft self-standing protein hydrogels that selectively deliver drugs, thereby enhancing medicinal effects while minimizing associated toxicity.

The test could help identify one key Alzheimer's biomarker, tau protein, before it shows up in brain. Here's what experts say ...

Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries Evrysdi tablet can be stored at room temperature and offers the same demonstrated efficacy and sa ...

"The Evrysdi tablet combines established efficacy with convenience, providing an additional flexible option for SMA management." The approval of the Evrysdi tablet was based on the results of a ...